Sterility concerns prompt recall of drugs from Fla. compounder

05/10/2013 | Modern Healthcare (subscription required)

The FDA warned pharmacists and doctors not to use treatments from The Compounding Shop, a specialty pharmacy in Florida, prompting it to notify customers and recall all of its sterile treatments. An inspection of the compounder raised concerns about sterility issues regarding its drugs that could cause bacterial contamination, the FDA said.

View Full Article in:

Modern Healthcare (subscription required)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA
Assistant General Counsel, Regulatorya
Cardinal Health
Waukegan, IL
Chief Operating Officer
Health Plan of San Joaquin
French Camp , CA